Bibliography
- NAYA A, SAGARA Y, OHWAKI K et al.: Design, synthesis, and discovery of a novel CCR1 antagonist. j Med. Chem. (2001) 44(9):1429–1435.
- ROSSI D, ZLOTNIK A: The biology of chemokines and their receptors. Ann. Rev brimurrol. (2000) 18:219–243.
- PROUDFOOT AE, POWER CA, WELLS TN: The strategy of blocking the chemokine system to combat disease. Immune] Rev (2000) 177:246–256.
- SALLUSTO F, MACKAY CR, LANZAVECCHIA A: The role of chemokine receptors in primary, effector, and memory immune responses. Ann. Rev brimurrol. (2000) 18:593–620.
- BAGGIOLINI M, MOSER B.: Blocking chemokine receptors. j Exp. Med. (1997) 186:1189–1191.
- WHITE JR, LEE JM, YOUNG PR et al: Identification of a potent, selective non- peptide CXCR2 antagonist that inhibits interleukin-8-mediated neutrophil migraton. Biol. Chem. (1998) 273:10095–10098.
- DONZELLA GA, SCHOLS D, UN SW et al.: AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat. Med. (1998) 4:72–77.
- MURAKAMI T, NAKAJIMA T, KOYANAGI N et al.: A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. j Exp. Med. (1997) 186:1389–1393.
- NG HP, MAY K, BAUMAN JG et al: Discovery of novel non-peptide CCR1 receptor antagonists. j Med. Chem. (1999) 42:4680–4694.
- LIANG M, ROSSER M, NG HP et al: Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor. Eur. j Pharmacy]. (2000) 389:41–49.
- PONATH PD, QIN S, POST TW et a/.: Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. j Exp. Med. (1996) 183:2437–2448.
- SABROE I, PECK MJ, VAN KEULEN BJ et al: A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry. j Biol. Chem. (2000) 275(34):25985–25992.
Patents
- TAKEDA CHEMICAL INDUSTRIES, LTD.: WO-9724325 (1997).
- BANYU PHARMACEUTICAL CO., LTD.:WO-9804554 (1998).